Recent
price
P/E
ratio
div
yld
0.70%
ROIC.AI
Warburg Pincus Hands Cash Back to Investors as Rivals Struggle
SARTORIUS (SARTF) Q3 Earnings Lag Estimates
SARTORIUS (SARTF) Q3 Earnings Lag Estimates
Short-Sellers Sink One of Europe’s Hottest Stocks
Sartorius’s Shares Drop on Outlook Cut, Preliminary 3Q Declines
Sartorius’s Shares Drop on Outlook Cut, Preliminary 3Q Declines
Sartorius Plunges as Covid Lab Equipment Provider Cuts Forecasts
Sartorius to Buy French Biotech Polyplus for $2.6 Billion
UPDATE 2-Sartorius to buy Polyplus for 2.4 bln euros
UPDATE 2-Sartorius to buy Polyplus for 2.4 bln euros
Nine-month results 2022 of Sartorius Stedim Biotech
Nine-month results 2022 of Sartorius Stedim Biotech
Sartorius Stedim Biotech to acquire Albumedix, strengthening its portfolio of innovative advanced therapy solutions
Sartorius Stedim Biotech to acquire Albumedix, strengthening its portfolio of innovative advanced therapy solutions
Half-year results 2022 of Sartorius Stedim Biotech
Half-year results 2022 of Sartorius Stedim Biotech
Sartorius records dynamic start to the new fiscal year
Sartorius records dynamic start to the new fiscal year
Resolutions of the Annual Shareholders' Meeting of Sartorius Stedim Biotech S.A.
Resolutions of the Annual Shareholders' Meeting of Sartorius Stedim Biotech S.A.
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.